RxDoctor Payments Data

Amber van Laar

Neurology · Pittsburgh, PANPI 1023246840

Payments from drug & device makers

What this record shows

This record is dominated by other: $412,360 of the $412,673 with a category attached, or 99.9%. Asklepios Biopharmaceutical Inc. accounts for 87.9% of it on its own, with 4 other manufacturers making up the rest. Among neurology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$412,673in general payments, 2019–2025

Across 9 payments — averaging $45,853 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Asklepios Biopharmaceutical Inc.$363K
  • Bayer$49K
  • Acadia Pharmaceuticals Inc$243
  • Boston Scientific$37
  • AbbVie$33
$347,115in research payments, 2019–2025

Across 34 payments — averaging $10,209 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$347K

What the payments were for

  • Food & beverage$3130%
  • Other$412,360100%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$412,673 in reported general payments places this provider in the 95th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania

Other neurology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →